Stock Screener App

Frei -

Installieren

2.28

8.57% 0.18

Cytomx Therapeutics Inc (CTMX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cytomx Therapeutics Inc-Aktie (CTMX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-06-30	2024-09-30	2023-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	63.36% 18.66	50.92	25.11	33.43	26.61
Operating Expenses	29.52% 19.94	28.30	33.57	29.32	27.21
Benefits Costs and Expenses	31.40% 18.75	27.33	31.60	27.64	24.70
Costs And Expenses	31.40% 18.75	27.33	31.60	27.64	24.70
Operating Income/Loss	105.68% -1.286	22.62	-8.452	4.111	-0.606
Income/Loss From Continuing Operations Before Tax	100.39% -0.091	23.59	-6.483	5.797	1.906
Income Tax Expense/Benefit	1.61% 0.063	0.062	0.051	0.061	1.069
Income/Loss From Continuing Operations After Tax	100.65% -0.154	23.52	-6.534	5.736	0.837
Net Income/Loss	100.65% -0.154	23.52	-6.534	5.736	0.837
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	48.16% 129.08	87.12	84.88	85.09	2.5828
Diluted Average Shares	48.11% 129.08	87.15	84.88	85.20	2.5828
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters